Sirolimus monotherapy for Erdheim-Chester disease

Acta Oncol. 2019 Jun;58(6):901-905. doi: 10.1080/0284186X.2019.1589648. Epub 2019 Mar 28.

Authors

Eric F H van Bommel¹, Mark A van der Zijden¹, Peter J H Smak Gregoor¹, Tadek R Hendriksz², Shiuw H Ho-Han³, Pieter J Westenend⁴

Affiliations

¹ a Department of Internal Medicine , Albert Schweitzer Hospital , Dordrecht , The Netherlands.
² b Department of Radiology , Albert Schweitzer Hospital , Dordrecht , The Netherlands.
³ c Department of Nuclear Medicine , Albert Schweitzer Hospital , Dordrecht , The Netherlands.
⁴ d Department of Pathology , Albert Schweitzer Hospital , Dordrecht , The Netherlands.

PMID: 30919713
DOI: 10.1080/0284186X.2019.1589648

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Erdheim-Chester Disease / diagnosis
Erdheim-Chester Disease / diagnostic imaging
Erdheim-Chester Disease / drug therapy*
Humans
Male
Middle Aged
Sirolimus / therapeutic use*

Substances

Sirolimus